Treatment of Severe Malaria Complications
For severe malaria complications, initiate intravenous artesunate immediately at 2.4 mg/kg at 0,12, and 24 hours, then daily, while providing targeted supportive care for each specific complication in an intensive care setting. 1
Antimalarial Therapy Foundation
All severe malaria treatment begins with parenteral artesunate as first-line therapy, regardless of the specific complication present 1, 2. This is non-negotiable and should be started urgently as soon as severe malaria is diagnosed 3. Once parasitemia drops below 1% and the patient can tolerate oral intake, transition to a full course of oral artemisinin-based combination therapy (ACT), preferably artemether-lumefantrine or dihydroartemisinin-piperaquine 1.
Critical caveat: If artesunate is unavailable, use intravenous quinine dihydrochloride (20 mg salt/kg loading dose over 4 hours, then 10 mg/kg every 8 hours), but this is clearly inferior 1.
Complication-Specific Management
Cerebral Malaria (Impaired Consciousness)
Airway management takes priority: Children with Glasgow Coma Score ≤8 or features of raised intracranial pressure require elective intubation and ventilation 4. For adults, similar thresholds apply 5.
- High-flow oxygen immediately upon presentation 4
- Ventilation strategy: Maintain PaCO₂ in normal range—hyperventilation provides no benefit and may worsen outcomes 4
- No adjunctive therapies have proven benefit (no steroids, no mannitol) 4, 6
- Monitor for delayed complications: Check for post-artesunate delayed hemolysis on days 7,14,21, and 28 1
Important pitfall: Do not use prophylactic anticonvulsants. Prophylactic phenobarbital increased mortality in African children, particularly when combined with benzodiazepines in unventilated patients 4.
Seizures
Follow this algorithmic approach 4:
- Immediate: High-flow oxygen and check glucose (hypoglycemia precipitates seizures)
- First-line: Lorazepam 0.1 mg/kg IV/IO, repeat once after 10 minutes if seizure continues
- Second-line: Paraldehyde 0.4 mg/kg rectally (0.8 ml/kg of prepared solution)
- Third-line: Either phenytoin 18 mg/kg IV over 20 minutes OR phenobarbital 15-20 mg/kg IV over 10 minutes
- Refractory: Call anesthesia for rapid sequence intubation with thiopental 4 mg/kg
Key point: 25% of seizures in severe malaria are subtle or subclinical, manifesting only as eye deviation, irregular breathing, or drooling 4. Maintain high suspicion.
Hypoglycemia
- Check glucose immediately in all severe malaria cases, especially those with seizures or altered consciousness 4
- Correct promptly with IV dextrose
- Monitor closely: Quinine causes insulin release and can precipitate recurrent hypoglycemia 1, 7
Acute Respiratory Distress Syndrome (ARDS)
- Fluid management is critical: Maintain intravascular volume at the lowest level sufficient for adequate systemic perfusion to prevent ARDS development 7
- Standard ARDS management protocols apply if it develops
- Mechanical ventilation with lung-protective strategies
Acute Renal Failure
- Initiate renal replacement therapy early 7
- Maintain adequate perfusion without fluid overload
- Monitor for recovery as parasitemia clears
Severe Anemia
- Transfuse as clinically indicated for symptomatic anemia or hemodynamic instability
- Monitor for post-artesunate delayed hemolysis (occurs 10 days to 3 weeks after treatment) 3
- Weekly hemoglobin checks for 4 weeks after treatment completion 1
Metabolic Acidosis and Shock
- Metabolic acidosis and hyperlactatemia strongly correlate with mortality 3
- Correct underlying cause (parasitemia clearance with artesunate)
- Judicious fluid resuscitation—avoid overload
- Vasopressor support as needed for shock
Thrombocytopenia and Bleeding
- Thrombocytopenia is common but not a WHO criterion for severe malaria 8
- Platelet transfusion only for active bleeding or invasive procedures
- Do not overtreat: Thrombocytopenia alone (even <50,000/mm³) without bleeding does not require parenteral artesunate 8
Monitoring Protocol
Daily assessments should include:
- Parasitemia every 12 hours until <1%, then every 24 hours until negative 1
- Complete blood count, renal function, liver enzymes, glucose, lactate 1
- Clinical neurological assessment
- Fluid balance
Post-discharge: Weekly hemoglobin checks for 4 weeks to detect delayed hemolysis 1, 3
Special Populations
Pregnancy (all trimesters): Intravenous artesunate is now the drug of choice 1, 2. Quinine can be used if artesunate unavailable 1.
Children: Same artesunate dosing (2.4 mg/kg) and complication management as adults 4, 2.